COVID-19Common question

When was Pfizer-biontech COVID-19 vaccine approved?

Pfizer-BioNTech (COMIRNATY) received U.S. Food and Drug Administration (FDA) approval on August 23, 2021, for individuals 16 years of age and older. Once vaccines are approved by the FDA, companies can market the vaccines under brand names. COMIRNATY is the brand name for the Pfizer-BioNTech COVID-19 Vaccine.

Is the COVID-19 vaccine approved by the FDA?

On December 11, 2020, the FDA issued an Emergency Use Authorization (EUA) for the use of the Pfizer-BioNTech COVID-19 Vaccine. On December 18, 2020, the FDA issued an EUA for the use of the Moderna COVID-19 Vaccine. And on February 27, 2021 the FDA issued an EUA for the use of the Janssen COVID-19 Vaccine.

Is the Pfizer-BioNTech COVID-19 vaccine authorized?

Pfizer-BioNTech COVID-19 Vaccine is authorized to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.

What is the first drug that was approved by the FDA to treat COVID-19?

Remdesivir is the first drug approved by the FDA for treatment of hospitalized COVID patients over the age of 12.

Is AstraZeneca COVID-19 vaccine approved by the FDA?

The AstraZeneca vaccine is not authorized for use in the U.S., but FDA understands that these AstraZeneca lots, or vaccine made from the lots, will now be exported for use.

Pfizer CEO explains why he hasn't received a vaccine yet

45 related questions found

Whaat happens if you mix AstraZeneca and Pfizer COVID-19 vaccines?

Researchers studied mixing and matching Pfizer's vaccine with AstraZeneca's, which is made using similar technology as J&J's. There, too, researchers found that people who got an AstraZeneca shot followed by Pfizer four weeks later produced more antibodies than those who received two AstraZeneca shots.

What vector is used in the AstraZeneca and Johnson & Johnson COVID-19 vaccines?

The virus vector being used in the Johnson & Johnson and AstraZeneca vaccines is an adenovirus, a common type of virus that typically causes mild cold symptoms when it infects someone.

COVID-19 viral vector vaccines inject a harmless adenovirus vector

For which COVID-19 patients has been approved Remdesivir?

On October 22, 2020, the FDA approved the antiviral drug Veklury (remdesivir) for use in adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.

What antiviral medication is approved to treat COVID-19?

Remdesivir (Veklury) is currently the only medication approved by the FDA to treat coronavirus disease 2019 (COVID-19). The approval was based on findings that hospitalized patients who got remdesivir (Veklury) recovered faster.

What is Remdesivir?

Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body.

When was Pfizer-BioNTech COVID-19 vaccine approved?

Pfizer-BioNTech (COMIRNATY) received U.S. Food and Drug Administration (FDA) approval on August 23, 2021, for individuals 16 years of age and older. Once vaccines are approved by the FDA, companies can market the vaccines under brand names. COMIRNATY is the brand name for the Pfizer-BioNTech COVID-19 Vaccine.

Is the Pfizer COVID-19 booster vaccine safe?

The additional dose was safe and tolerable, and consistent with what was known about the vaccine, the companies said. The study was carried out while the highly contagious Delta variant was prevalent, the companies said, suggesting the booster helps protect against the contagious strain.

When was the Pfizer COVID-19 vaccine approved for emergency use?

• On Dec. 11, 2020, FDA issued the first Emergency Use Authorization (EUA) for use of the Pfizer-BioNTech COVID-19 Vaccine in people aged 16 years and older, and on Dec. 13, 2020, ACIP issued recommendations for use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19.

Is it safe to take the COVID-19 vaccine?

COVID-19 vaccines are safe and effective. Vaccines cannot give you COVID-19. You may have side effects after vaccination. These are normal, and should go away in a few days.

When was the Moderna COVID-19 vaccine approved?

Moderna COVID-19 Vaccine
On December 18, 2020, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Who should not get the Moderna COVID-19 vaccine?

If you have had a severe allergic reaction (anaphylaxis) or an immediate allergic reaction, even if it was not severe, to any ingredient in an mRNA COVID-19 vaccine (such as polyethylene glycol), you should not get an mRNA COVID-19 vaccine.

What is Banlanivimab, one of the antibody drug that is approved to treat COVID-19?

Monoclonal antibodies are laboratory-made proteins that mimic the immune system's ability to fight off harmful antigens such as viruses. Bamlanivimab is a monoclonal antibody that is specifically directed against the spike protein of SARS-CoV-2, designed to block the virus’ attachment and entry into human cells.

Is Remdesivir used in treating COVID-19?

Conclusions: Remdesivir can help improve the clinical outcome of hospitalized patients with COVID-19 and a 5 day regimen, instead of a 10 day regimen, may be sufficient for treatment. Moreover, remdesivir appears as tolerable as other comparators or placebo.

Is Remdesivir approved in Europe for treatment of COVID-19?

Since July 2020, remdesivir has been conditionally approved in Europe for the treatment of coronavirus disease (COVID-19) in adults and adolescents aged 12 years and older with pneumonia who require supplemental oxygen but no invasive ventilation.

What treatments are available for COVID-19?

On October 22, 2020, the FDA approved the antiviral drug Veklury (remdesivir) for use in adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.

Has the FDA approved remdesivir to treat COVID-19?

The FDA has approved an antiviral drug called remdesivir to treat COVID-19 in adults and children who are age 12 and older. Remdesivir may be prescribed for people who are hospitalized with COVID-19. It's given through a needle in the skin (intravenously).

Is remdesivir approved for use in adults and children at least 12 years old to treat COVID-19?

Remdesivir is used to treat people with coronavirus disease 2019 (COVID-19) who are in a hospital.
Remdesivir is approved for use in adults and children at least 12 years old who weigh at least 88 pounds (40 kilograms).

How does the Johnson and Johnson COVID-19 vaccine work?

The Johnson & Johnson product is an adenovirus vaccine or a viral vector vaccine. Here is how it works.

The Johnson & Johnson vaccine delivers the virus' DNA to your cells to make the spike protein. An adenovirus acts as a delivery vehicle used to carry the coronavirus genetic material (DNA).

What are the ingredients in the Janssen COVID-19 vaccine?

The Janssen COVID-19 Vaccine includes the following ingredients: recombinant, replication-incompetent adenovirus type 26 expressing the SARS-CoV-2 spike protein, citric acid monohydrate, trisodium citrate dihydrate, ethanol, 2-hydroxypropyl-β-cyclodextrin (HBCD), polysorbate-80, sodium chloride.

Does the mRNA covid-19 vaccine have eggs or gelatin?

In addition, because the mRNA COVID-19 vaccines do not contain eggs or gelatin, persons with allergies to these substances do not have a contraindication or precaution to vaccination.